Oral administration of KW-5092, a novel gastroprokinetic agent with acetylcholinesterase inhibitory and acetylcholine release enhancing activities, causes a dose-dependent increase in the blood acetylcholine content of beagle dogs (Q42438154)
Jump to navigation
Jump to search
scientific article published on March 1997
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Oral administration of KW-5092, a novel gastroprokinetic agent with acetylcholinesterase inhibitory and acetylcholine release enhancing activities, causes a dose-dependent increase in the blood acetylcholine content of beagle dogs |
scientific article published on March 1997 |
Statements
1 reference
Oral administration of KW-5092, a novel gastroprokinetic agent with acetylcholinesterase inhibitory and acetylcholine release enhancing activities, causes a dose-dependent increase in the blood acetylcholine content of beagle dogs (English)
1 reference
Yamada S
1 reference
Fujii T
1 reference
Kawashima K
1 reference
1 March 1997
1 reference
1 reference
Identifiers
1 reference